Wafik S. El-Deiry on cancer in RI and the progress in recent years

Wafik S. El-Deiry shared on X:

” Glad to have a chance to speak to the audience about cancer in RI and the progress in recent years at Legorreta Cancer Center at Brown University, The Warren Alpert Medical School, Brown University, Legorreta Cancer Center  in building research programs, infrastructure, community outreach, and a superb cancer clinical trials program.

There are numerous opportunities for interdisciplinary collaborations in RNA biology, metabolism, hypoxia, senescence, drug repurposing, and neuroscience.

All of these areas that were discussed at today’s retreat by other disciplines here at Brown illustrate the great potential we have here in RI to have great impact on the fields of cancer research and clinical oncology.”

Wafik S. El-Deiry, MD, PhD, FACP, FRSM, is the Associate Dean for Oncologic Sciences at the Warren Alpert Medical School and Director of the Legorreta Cancer Center   Brown University and Director of the Joint Program in Cancer Biology at Brown University and affiliated hospitals. He is the Editor in Chief at Oncotarget. Dr. El-Deiry discovered p21(WAF1) as a p53 target gene, cell cycle inhibitor, and tumor suppressor that explained the mammalian cell stress response. Dr. El-Deiry’s research is focused on mechanisms of therapy resistance with major efforts in drug discovery and development.